Snyder Capital Management L P Halozyme Therapeutics, Inc. Call Options Transaction History
Snyder Capital Management L P
- $4.49 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding HALO
# of Institutions
441Shares Held
122MCall Options Held
216KPut Options Held
140K-
Black Rock Inc. New York, NY18.2MShares$936 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$669 Million0.01% of portfolio
-
State Street Corp Boston, MA6.49MShares$333 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.79MShares$194 Million0.24% of portfolio
-
Alliancebernstein L.P. New York, NY3.67MShares$188 Million0.05% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.15B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...